EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer to Drive Scientific Strategy EpiVax has announced the appointment of Dr. Vibha Jawa as Chief Scientific Officer, succeeding founder Annie De Groot. Dr. Jawa brings over 20 years of expertise in biopharmaceuticals.

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer to Drive Scientific Strategy #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer, Promising Innovative Advancements EpiVax has appointed Dr. Vibha Jawa as its new Chief Scientific Officer. With over 20 years in biotech, she will lead advancements in immunogenicity.

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer, Promising Innovative Advancements #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

EpiVax Welcomes Dr. Vibha Jawa as the New Chief Scientific Officer to Enhance Scientific Strategy EpiVax announces the appointment of Dr. Vibha Jawa as Chief Scientific Officer, aiming to further their mission in immunogenicity assessment and biologic therapeutics.

EpiVax Welcomes Dr. Vibha Jawa as the New Chief Scientific Officer to Enhance Scientific Strategy #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

EpiVax Welcomes Dr. Vibha Jawa as Chief Scientific Officer to Propel Innovation EpiVax appoints Dr. Vibha Jawa as Chief Scientific Officer, marking a pivotal leadership transition aimed at advancing immunogenicity assessment in biologics.

EpiVax Welcomes Dr. Vibha Jawa as Chief Scientific Officer to Propel Innovation #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa